Study details
Enrolling now
Oral Cannabidiol for Tobacco Cessation
Johns Hopkins University
NCT IDNCT05445804ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
50
Study length
about 3.3 years
Ages
18–65
Locations
1 site in MD
About this study
Researchers are testing whether oral cannabidiol helps people quit smoking. The trial will see if cannabidiol increases short-term tobacco abstinence and explore how it might change smoking behavior. This is a Phase 1 trial with adults, aiming to enroll about 50 participants over 1188 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take 300 mg Cannabidiol
- 2.Take 600 mg Cannabidiol
- 3.Take Placebo
PhasePhase 1
Drug300 mg Cannabidiol
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
cannabidiol
Drug routes
oral (Oral Solution)
Endpoints
Secondary: Tobacco Withdrawal as assessed by the Hospital Anxiety and Depression Scale